250 related articles for article (PubMed ID: 36863196)
1. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
3. MRI/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe
Qiao H; Wang Y; Zhang R; Gao Q; Liang X; Gao L; Jiang Z; Qiao R; Han D; Zhang Y; Qiu Y; Tian J; Gao M; Cao F
Biomaterials; 2017 Jan; 112():336-345. PubMed ID: 27788352
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
[TBL] [Abstract][Full Text] [Related]
5. In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles.
Wang Y; Chen J; Yang B; Qiao H; Gao L; Su T; Ma S; Zhang X; Li X; Liu G; Cao J; Chen X; Chen Y; Cao F
Theranostics; 2016; 6(2):272-86. PubMed ID: 26877785
[TBL] [Abstract][Full Text] [Related]
6. T1-weighted MRI of targeting atherosclerotic plaque based on CD40 expression on engulfed USPIO's cell surface.
Huang C; Huang W; Meng Y; Zhou C; Wang X; Zhang C; Tian Y; Wei W; Li Y; Zhou Q; Chen W; Tang Y
Biomed Mater; 2024 Jan; 19(2):. PubMed ID: 38215489
[TBL] [Abstract][Full Text] [Related]
7. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
[TBL] [Abstract][Full Text] [Related]
9. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating.
Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979
[TBL] [Abstract][Full Text] [Related]
10. Dual-modality imaging of atherosclerotic plaques using ultrasmall superparamagnetic iron oxide labeled with rhodamine.
Li Y; Pan Y; Wu X; Li Y; Wang H; Zhu H; Jiang L
Nanomedicine (Lond); 2019 Aug; 14(15):1935-1944. PubMed ID: 31355711
[No Abstract] [Full Text] [Related]
11. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
12. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
13. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).
Smith BR; Heverhagen J; Knopp M; Schmalbrock P; Shapiro J; Shiomi M; Moldovan NI; Ferrari M; Lee SC
Biomed Microdevices; 2007 Oct; 9(5):719-27. PubMed ID: 17562181
[TBL] [Abstract][Full Text] [Related]
14. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.
Sekita A; Unterweger H; Berg S; Ohlmeyer S; Bäuerle T; Zheng KH; Coolen BF; Nederveen AJ; Cabella C; Rossi S; Stroes ESG; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2024; 19():1645-1666. PubMed ID: 38406599
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
17. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI.
Qi CM; Du L; Wu WH; Li DY; Hao J; Gong L; Deng L; Zhang T; Zhang C; Zhang Y
Cell Biochem Biophys; 2015 Nov; 73(2):331-337. PubMed ID: 27352319
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
